Physicians Financial Services’s Xylem XYL Stock Holding History

Physicians Financial Services’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-300	Closed	-$14K	–	270
2016 Q4	$14K	Hold	300	–	–	0.01%	221
2016 Q3	$15K	Hold	300	–	–	0.01%	209
2016 Q2	$13K	Hold	300	–	–	0.01%	213
2016 Q1	$12K	Hold	300	–	–	0.01%	214
2015 Q4	$11K	Buy	+300	New	+$10.8K	0.01%	229

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Physicians Financial Services's XYL Position: Q1 2017 in Review

Physicians Financial Services sold out of Xylem (XYL) in Q1 2017, closing a stake of 300 shares — an estimated $14K sold.

Physicians Financial Services first reported a position in XYL in Q4 2015 and held it in 5 quarters. The position peaked at $15K in Q3 2016. 546 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

Physicians Financial Services reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
Physicians Financial Services sold 300 Xylem shares in Q1 2017, an estimated $14K.
Physicians Financial Services first reported a position in Xylem in Q4 2015 and held it in 5 quarters.
Physicians Financial Services's Xylem position peaked at $15K in Q3 2016.
546 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on Physicians Financial Services's 13F filing for Q1 2017, filed 26 Apr 2017.